Japan Polycystic Ovarian Syndrome (PCOS/PCOD) Analysis


  • Type: Common Disease Area
  • Published : January 2022
  • Region: Asia
  • Country: Japan
  • Report ID : 5033

  • Format: PPT, PDF

Japan Polycystic Ovarian Syndrome (PCOS/PCOD) Analysis: Segmented by Drug type, By Surgery Outlook – Growth, Market Size, Future Prospects & Competitive Analysis, 2020–2028

SKU: 5033 Categories: ,

Report Description of the Polycystic Ovarian Syndrome (PCOS/PCOD) Treatment Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for Polycystic Ovarian Syndrome  Treatment Market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Polycystic Ovarian Syndrome  Treatment market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

Japan Polycystic Ovarian Syndrome (PCOS/PCOD) Treatment Executive Summary

Polycystic ovary syndrome or PCOS is a hormonal disorder that is common among women of childbearing age. PCOS causes infrequent or prolonged menstrual cycle or excess male hormone levels. Presently, there is no cure for PCOS, however, various medications are used to regulate menstrual cycle and to manage symptoms of PCOS.

Market Size and Key Findings

The Japan Polycystic Ovarian Syndrome (PCOS / PCOD) Treatment Market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Market Dynamics

Market Growth Drivers Analysis

Increase in prevalence of PCOS, rise in awareness among patient population with increase in adoption of combination therapy drives the polycystic ovarian syndrome treatment market growth. In addition, easy accessibility to PCOS therapeutics, rise in demand for PCOS medications, and technological advancements for detection of PCOS influence the market growth.

Market Restraints

Lack of approved therapeutics, and unknown etiology and pathophysiology of PCOS is anticipated to hamper the market growth. Furthermore, untapped potential offered by developing economies present lucrative opportunities for the growth of the polycystic ovarian syndrome treatment market during the forecast period. However, lack of specific treatment for PCOS disorder is expected to restrain the growth of the market. The rise in prevalence of PCOS is expected to augment the demand for PCOS treatment medications.

Competitive Landscape

Key Players

The major market players are focusing on symptomatic treatments and several have their drugs in clinical trials, but not approved for marketing. There is a growing focus on surgeries, for which many medical devices are inclined towards. Some of the major players in the market are Bayer AG, Ferring BV, Merck KGaA, Novartis, Pfizer, and Takeda, Teva Pharmaceutical Industries Limited, among others.

Products in Pipeline

Currently, no drugs are approved by the FDA and EMA for PCOS. However, oral contraceptives, insulin sensitizing agents, and aromatase inhibitors are used as first line agents for the treatment of irregular menstruation, diabetes, and facial hair growth respectively.

Notable Recent Deals

Evotec SE and Bayer AG announced the expansion of their partnership in women’s health indications with a new five-year, multi-target collaboration with participation from Celmatix Inc. to develop multiple clinical candidates for the treatment of polycystic ovary syndrome (“PCOS”). Under the terms of the agreement, both companies will contribute drug targets and a comprehensive set of high-quality technology platforms to jointly develop innovative treatment options.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

In 2006 the Japanese Society of Obstetrics and Gynecology (JSOG) proposed new, revised diagnostic criteria that in the future could also be valued internationally. Based on the new diagnostic criteria, the JSOG has also proposed the revised treatment criteria in 2008. In PCOS obese patients desiring children, weight loss and exercise is recommended.

1. Report Description of the Japan Polycystic Ovarian Syndrome (PCOS / PCOD) Treatment Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Japan Polycystic Ovarian Syndrome (PCOS / PCOD) Treatment Executive Summary
2.1 Japan Polycystic Ovarian Syndrome Market – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of Japan Polycystic Ovarian Syndrome (PCOS / PCOD) Treatment market
3.1 Market Growth Drivers Analysis
3.1.1 Increase in prevalence of PCOS
3.1.2 Rise in awareness among patient
3.1.3 Adoption of combination therapy
3.2 Market Restraints Analysis
3.2.1 Lack of approved therapeutics
3.2.2 Unknown etiology and pathophysiology of PCOS
4. Polycystic Ovarian Syndrome Treatment Market Segmentation
4.1 By Drug Type Analysis:
4.1.1 Oral Contraceptives
4.1.2 Antiandrogens
4.1.3 Insulin-sensitizing Agent
4.1.4 Antidepressant
4.1.5 Anti-obesity
4.2 By Surgery Outlook Analysis:
4.2.1 Ovarian Wedge Resection
4.2.2 Laparoscopic Ovarian Drilling
4.2.3 Others
5. Polycystic Ovarian Syndrome Major Products Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Polycystic Ovarian Syndrome Drugs Market
6.4 Notable recent deals in Polycystic Ovarian Syndrome Drugs Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Bayer AG Company overview
Product & Services, Strategies & Financials
7.2 Ferring BV Company overview
Product & Services, Strategies & Financials
7.3 Merck KGaA Company overview
Product & Services, Strategies & Financials
7.4 Novartis Company overview
Product & Services, Strategies & Financials
7.5 Pfizer Company overview
Product & Services, Strategies & Financials
7.6 Takeda Company overview
Product & Services, Strategies & Financials
7.7 Teva Pharmaceutical
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Polycystic Ovarian Syndrome Drugs market
9.2 Future Opportunities
10. Strategic Recommendations

Polycystic Ovarian Syndrome Treatment Market Segmentation

By Drug Type:

By drug class, the market is categorized into insulin sensitizing agent, oral contraceptive, antiandrogens, anti-obesity drugs, and others. Presently, the insulin sensitizing agent segment is the major revenue contributing segment in 2018 and is estimated to show a significant market growth during the forecast period due to higher adoption of insulin sensitizing agents as the first line treatment for the management of PCOS.

By Surgery Outlook

Based on the surgery, the market is divided into laparoscopic ovarian drilling and ovarian wedge resection. When drug therapy proves to be ineffective, surgery is recommended for treatment. The most common surgeries performed for treatment of PCOS include ovarian wedge resection and laparoscopic drilling of ovaries. Some of the other procedures that are performed are oophorectomy, hysterectomy, and cyst aspiration.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements